Lind Global Fund II LP 13D and 13G filings for ABVC BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:13 pm Purchase |
2024-12-31 | 13G | ABVC BioPharma, Inc. ABVC |
Lind Global Fund II LP | 1,325,000 9.900% |
175,000 (+15.22%) |
Filing |
| 2024-11-14 7:33 pm Purchase |
2024-09-30 | 13G | ABVC BioPharma, Inc. ABVC |
Lind Global Fund II LP | 1,150,000 9.900% |
380,000 (+49.35%) |
Filing |
| 2024-02-13 7:59 pm Purchase |
2023-12-31 | 13G | ABVC BioPharma, Inc. ABVC |
Lind Global Fund II LP | 770,000 9.900% |
770,000 (New Position) |
Filing |